Literature DB >> 15620471

Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana.

N G Saravia1, M H Hazbón, Y Osorio, L Valderrama, J Walker, C Santrich, T Cortázar, J H Lebowitz, B L Travi.   

Abstract

Paraflagellar rod proteins (PFR) are a potent immunogen against experimental Trypanosoma cruzi infection. PFR are highly conserved among kinetoplastid parasites. We therefore evaluated the immunogenicity of the Leishmania mexicana pfr-2 gene and protein product in the hamster model of American cutaneous leishmaniasis. Immunization with pfr-2 DNA-induced specific antibody, confirming immunogenicity. Subsequent challenge with 10,000 and 500 stationary phase L. mexicana promastigotes respectively, resulted in delayed appearance of lesions, and significant reduction in lesions post infection in male hamsters, yet exacerbated lesions in female hamsters. Immunization with recombinant PFR-2 protein (rPFR-2) prevented lesion development in female hamsters challenged with L. panamensis, but was ineffective against L. mexicana. Nevertheless, prime boost immunization of female hamsters with rPFR and pfr-2 DNA significantly reduced lesion size following challenge with 500 L. mexicana promastigotes, supporting the relevance of PFR-2 as a potential vaccine constituent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15620471     DOI: 10.1016/j.vaccine.2004.07.044

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

Review 1.  An overview on kinetoplastid paraflagellar rod.

Authors:  B R Maharana; A K Tewari; Veer Singh
Journal:  J Parasit Dis       Date:  2014-02-07

2.  Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis.

Authors:  Marie Breton; Michel J Tremblay; Marc Ouellette; Barbara Papadopoulou
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Epitope-Binding Characteristics for Risk versus Protective DRB1 Alleles for Visceral Leishmaniasis.

Authors:  Toolika Singh; Michaela Fakiola; Joyce Oommen; Akhil Pratap Singh; Abhishek K Singh; Noel Smith; Jaya Chakravarty; Shyam Sundar; Jenefer M Blackwell
Journal:  J Immunol       Date:  2018-03-05       Impact factor: 5.422

Review 4.  The development and clinical evaluation of second-generation leishmaniasis vaccines.

Authors:  Malcolm S Duthie; Vanitha S Raman; Franco M Piazza; Steven G Reed
Journal:  Vaccine       Date:  2011-11-12       Impact factor: 3.641

5.  The Trypanosoma cruzi flagellum is discarded via asymmetric cell division following invasion and provides early targets for protective CD8⁺ T cells.

Authors:  Samarchith P Kurup; Rick L Tarleton
Journal:  Cell Host Microbe       Date:  2014-10-08       Impact factor: 21.023

Review 6.  The paraflagellar rod of kinetoplastid parasites: from structure to components and function.

Authors:  Neil Portman; Keith Gull
Journal:  Int J Parasitol       Date:  2009-10-30       Impact factor: 3.981

7.  Leishmaniasis Vaccine: Where are We Today?

Authors:  Lukasz Kedzierski
Journal:  J Glob Infect Dis       Date:  2010-05

8.  Molecular Cloning, Expression and Characterization of Para Flagellar Rod Protein 1 of Trypanosoma evansi.

Authors:  Biswa Ranjan Maharana; Anup Kumar Tewari; Naduvanahalli Rajanna Sudhakar; Chinmoy Mishra
Journal:  Iran J Parasitol       Date:  2018 Oct-Dec       Impact factor: 1.012

9.  Combining RNA interference mutants and comparative proteomics to identify protein components and dependences in a eukaryotic flagellum.

Authors:  Neil Portman; Sylvain Lacomble; Benjamin Thomas; Paul G McKean; Keith Gull
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

10.  DNA Vaccines against Protozoan Parasites: Advances and Challenges.

Authors:  Eric Dumonteil
Journal:  J Biomed Biotechnol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.